N-nitrosamine risk assessment in pharmaceuticals: Where are we from a regulatory point of view in 2025?

Guidance, Documents, Resources
1

Really well put together article from Yue Zhang, et al. covering the full risk assessment/control strategy process.

https://doi.org/10.1016/j.jpbao.2025.100084

3 Likes